Group | Time | N | Posture score | Behavior viewed from a distance score | Behavior following social interaction score | Paw pain on palpation score | Soft tissue incision site pain on palpation score | Overall pain control score | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean (SD) | P value | Mean (SD) | P value | Mean (SD) | P value | Mean (SD) | P value | Mean (SD) | P value | Mean (SD) | P value | |||
Robenacoxib | 0 | 175 | 3.72 (0.83) | 0.85 | 1.18 (0.51) | 0.95 | 1.99 (1.19) | 0.78 | 4.82 (0.49) | 0.72 | 1.06 (0.27) | 0.51 | 1.11 (0.35) | 0.75 |
Placebo | 173 | 3.70 (0.89) | 1.17 (0.51) | 1.97 (1.21) | 4.86 (0.41) | 1.02 (0.15) | 1.09 (0.32) | |||||||
Robenacoxib | 30 min | 175 | 3.06 (1.06) | 0.54 | 1.31 (0.55) | 0.19 | 1.92 (1.04) | 0.26 | 4.39 (0.96) | 0.12 | 1.24 (0.55) | 0.60 | 1.36 (0.56) | 0.12 |
Placebo | 173 | 2.99 (1.12) | 1.23 (0.49) | 1.80 (0.93) | 4.56 (0.68) | 1.21 (0.43) | 1.25 (0.50 | |||||||
Robenacoxib | 1 h | 175 | 2.65 (1.16) | 0.24 | 1.35 (0.56) | 0.049 | 1.88 (0.95) | 0.042 | 4.19 (1.08) | 0.052 | 1.37 (0.59) | 0.0067 | 1.50 (0.65) | 0.0050 |
Placebo | 173 | 2.52 (1.18) | 1.24 (0.49) | 1.67 (0.89) | 4.40 (0.93) | 1.20 (0.47) | 1.31 (0.59) | |||||||
Robenacoxib | 3 h | 175 | 2.32 (1.15) | 0.0022 | 1.43 (0.61) | 0.0086 | 1.81 (0.92) | 0.0079 | 3.73 (1.27) | <0.0001 | 1.53 (0.73) | 0.0001 | 1.66 (0.75) | <0.0001 |
Placebo | 173 | 1.98 (1.07 | 1.27 (0.53) | 1.53 (0.84) | 4.22 (0.96) | 1.30 (0.52) | 1.37 (0.65) | |||||||
Robenacoxib | 5 h | 175 | 2.21 (1.07) | 0.0001 | 1.49 (0.66) | 0.0001 | 1.83 (0.94) | 0.0011 | 3.57 (1.37) | <0.0001 | 1.60 (0.76) | 0.0076 | 1.78 (0.82) | <0.0001 |
Placebo | 173 | 1.78 (0.93) | 1.26 (0.53) | 1.50 (0.81) | 4.02 (1.02) | 1.44 (0.57) | 1.43 (0.68) | |||||||
Robenacoxib | 8 h | 175 | 2.10 (1.07) | 0.0001 | 1.50 (0.68) | <0.0001 | 1.81 (0.93) | 0.0006 | 3.52 (1.33) | 0.0008 | 1.65 (0.75) | 0.0017 | 1.83 (0.82) | <0.0001 |
Placebo | 173 | 1.66 (0.87) | 1.20 (0.51) | 1.45 (0.77) | 3.88 (1.06) | 1.46 (0.60) | 1.43 (0.67) | |||||||
Robenacoxib | 24 h | 107 | 1.32 (0.61) | ND | 1.07 (0.25) | ND | 1.21 (0.49) | ND | 4.11 (1.0) | ND | 1.34 (0.58) | ND | 1.18 (0.45) | ND |
Placebo | 146 | 1.36 (0.60) | 1.05 (0.23) | 1.25 (0.59) | 3.99 (1.05) | 1.39 (0.59) | 1.22 (0.51) | |||||||
Robenacoxib | 28 h | 104 | 1.36 (0.67) | ND | 1.04 (0.19) | ND | 1.13 (0.39) | ND | 4.16 (0.92) | ND | 1.33 (0.57) | ND | 1.16 (0.37) | ND |
Placebo | 140 | 1.26 0.54 | 1.04 (0.19) | 1.19 (0.46) | 3.99 (0.92) | 1.37 (0.55) | 1.16 (0.39) | |||||||
Robenacoxib | 32 h | 102 | 1.30 (0.63) | ND | 1.02 (0.14) | ND | 1.13 (0.36) | ND | 4.14 (1.02) | ND | 1.30 (0.56) | ND | 1.13 (0.34) | ND |
Placebo | 139 | 1.24 (0.49) | 1.02 (0.15) | 1.17 (0.45) | 4.01 (0.93) | 1.37 (0.56) | 1.17 (0.37) | |||||||
Robenacoxib | 48 h | 102 | 1.23 (0.51) | ND | 1.01 (0.10) | ND | 1.10 (0.33) | ND | 4.06 (0.98) | ND | 1.26 (0.56) | ND | 1.12 (0.32) | ND |
Placebo | 139 | 1.15 (0.38) | 1.01 (0.12) | 1.09 (0.36) | 3.96 (0.95) | 1.28 (0.50) | 1.07 (0.26) | |||||||
Robenacoxib | 52 h | 102 | 1.20 (0.47) | ND | 1.01 (0.10) | ND | 1.11 (0.34) | ND | 4.11 (0.92) | ND | 1.28 (0.55) | ND | 1.10 (0.30) | ND |
Placebo | 139 | 1.12 (0.35) | 1.02 (0.15) | 1.09 (0.36) | 4.07 (0.94) | 1.27 (0.52) | 1.06 (0.24) |